Education
About Us
Working with TipRanks
Follow Us
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 54.55M | $ 76.99M | $ 38.63M | $ 29.75M | $ 17.82M |
| Gross Profit | $ -167.08M | $ -112.16M | $ -145.87M | $ -86.68M | $ -48.67M |
| Operating Income | $ -213.03M | $ -155.06M | $ -183.87M | $ -117.89M | $ -64.98M |
| EBITDA | $ -205.01M | $ -148.93M | $ -179.72M | $ -115.90M | $ -62.80M |
| Net Income | $ -193.57M | $ -143.95M | $ -180.36M | $ -117.19M | $ -43.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 609.58M | $ 287.91M | $ 309.14M | $ 295.72M | $ 281.15M |
| Total Assets | $ 669.34M | $ 355.60M | $ 416.76M | $ 476.77M | $ 396.34M |
| Total Debt | $ 28.30M | $ 30.61M | $ 11.96M | $ 13.04M | $ 0.00 |
| Net Debt | $ -81.69M | $ -24.01M | $ -52.51M | $ -67.47M | $ -119.36M |
| Total Liabilities | $ 142.35M | $ 155.10M | $ 113.06M | $ 134.47M | $ 106.07M |
| Stockholders' Equity | $ 526.99M | $ 200.49M | $ 303.70M | $ 342.30M | $ 290.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -181.86M | $ -89.77M | $ -172.05M | $ -90.03M | $ -4.63M |
| Operating Cash Flow | $ -172.58M | $ -81.36M | $ -159.81M | $ -84.36M | $ -80.00K |
| Investing Cash Flow | $ -257.71M | $ 68.30M | $ 27.20M | $ -108.25M | $ -254.40M |
| Financing Cash Flow | $ 485.67M | $ 3.22M | $ 117.19M | $ 153.88M | $ 339.02M |